2022 So far In Venture Capital

Precision and personalized medicine: deals decreased significantly in clinical trials in H2 2021

Deals relating to precision and personalized medicine have seen a decrease of 54.1% from H2 2020 to H2 2021.


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.